primary central nervous system hodgkin lymphoma

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Primary CNS Hodgkin Lymphoma Trial in Hangzhou (Orelabrutinib, Sintilimab)

Recruiting
  • Primary Central Nervous System Hodgkin Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 14, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +117 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Jun 28, 2018

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +62 more
  • Duarte, California
  • +10 more
Feb 21, 2014

Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, MALT Trial in Columbus (gemcitabine HCl, triapine)

Completed
  • Anaplastic Large Cell Lymphoma
  • +58 more
  • Columbus, Ohio
    Ohio State University Medical Center
Sep 27, 2013